Menstrual ManagementNCT07382947
MENSTRUATİON MANAGEMENT ACCORDİNG TO GENERATİONS
A study testing survey data entry in people with Menstrual Management and Generational Differences, run by Batman University at 1 site in Turkey (Türkiye).
Trial summary
The most common symptom that occurs during the menstrual cycle is cramping pain in the lower abdomen. This pain during the menstrual cycle is called dysmenorrhea. It is one of the most common causes of pelvic pain in women. Dysmenorrhea is categorized into two types: primary and secondary. Read more about this study
- Who is it for?
- Ages 18 to 55 years, women only
- Conditions the study is for
- Menstrual Management, Generational Differences, Womens Health
- What is being tested?
- survey data entry
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,200 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Nov 2025to 10 Jan 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Being female
- Being between 18-55 years of age
- Having a menstrual cycle
- Voluntarily agreeing to participate in the study
- Approving the informed consent form
Who cannot join
- Having a serious chronic or neurological disease
- Using hormonal treatment or birth control method (within the last 6 months)
- Being pregnant or in menopause
- Having an incomplete or incorrectly completed questionnaire
Trial locations and contacts
1 site in 1 country.
About this study
Official title: EXAMINING MENSTRUAL MANAGEMENT AMONG WOMEN OF DIFFERENT GENERATIONS
The most common symptom that occurs during the menstrual cycle is cramping pain in the lower abdomen. This pain during the menstrual cycle is called dysmenorrhea. It is one of the most common causes of pelvic pain in women. Dysmenorrhea is categorized into two types: primary and secondary. Primary dysmenorrhea manifests as painful cramps during the menstrual period without a pelvic pathology. The pain can radiate to the lower back, pelvis, and upper thigh. Although the etiology of primary dysmenorrhea is not fully known, four main causes have been identified. The etiology of primary dysmenorrhea is endocrine causes, increased prostaglandin levels, increased uterine activity, and psychological causes. Among these factors, increased uterine contractions are thought to be particularly effective in causing the pain. Ischemia in the uterus, which occurs with increased contractions, is among the factors that increase the pain. Primary dysmenorrhea has a prevalence ranging from 45% to 95%. Secondary dysmenorrhea, on the other hand, results from underlying pathological causes such as endometriosis, adenomyosis, uterine fibroids, or pelvic infections. Common symptoms of dysmenorrhea include lower abdominal pain along with headache, numbness, sleep disturbances, depression, vomiting, tender breasts, nausea, diarrhea, and increased urine output.
Read the detailed description
Research objective/rational: The menstrual cycle (MCC) is a physiological process lasting 23-35 days, consisting of two main phases: follicular (from menstruation to ovulation) and luteal (from ovulation to menstruation), characterized by regular fluctuations in estrogen and progesterone hormones. During the menstrual period, estrogen and progesterone levels are low, while in the follicular phase, estrogen increases and peaks at ovulation; at this time, the increase in FSH and LH triggers ovulation. In the luteal phase, progesterone levels rise and peak in the mid-luteal phase, while a second increase in estrogen levels is observed. When fertilization does not occur, both hormones rapidly decrease in the premenstrual period. Mood changes along with these hormonal fluctuations; negative mood increases during the premenstrual and menstrual periods, while positive mood increases during the ovulation period. These changes can negatively affect women's physical activities, work performance, social relationships, and quality of life. The literature reports that women lose more workdays due to health reasons compared to men, and one of the important reasons for this is symptoms associated with the menstrual cycle.
- Being tested
- survey data entry
- Keywords
- menstrual management, generational differences, womens health, menstrual health
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
survey data entryOther
survey data entry
| Study group | Role | What they receive |
|---|---|---|
| X generation | Active comparator | Data will be collected online (Google Forms) on a voluntary basis. At the beginning of the survey, participants will be presented with the purpose of the research, privacy principles, and an informed consent form. Receives: Other: survey data entry |
| Y Generation | Active comparator | Data will be collected online (Google Forms) on a voluntary basis. At the beginning of the survey, participants will be presented with the purpose of the research, privacy principles, and an informed consent form. Receives: Other: survey data entry |
| Z Generation | Active comparator | Data will be collected online (Google Forms) on a voluntary basis. At the beginning of the survey, participants will be presented with the purpose of the research, privacy principles, and an informed consent form. Receives: Other: survey data entry |
What is being measured
The primary outcome is the main question the study is designed to answer.
Menstruation Symptom Scale (MSQ)
Developed by Chesney and Tasto in 1975, the MSQ was adapted into Turkish by Güvenç et al. in 2014.
The scale is a five-point Likert-type scale consisting of 22 items. Participants rate menstruation-related symptoms on a scale of 1 (never) to 5 (always).
The scale is divided into three sub-dimensions: 'Negative Effects/Somatic Complaints', 'Menstrual Pain Symptoms', and 'Coping Mechanisms'.
The MSQ score is calculated from the average scores of the items, and a higher score indicates an increase in the severity of symptoms.
Measured: 15 minute
Attitude Toward Menstrution Scale:
Attitude Toward Menstruation Scale: The Turkish validity and reliability study of the scale developed by Brooks-Gunn and Ruble in 1980 was conducted by Kulakaç et al. in 2008. The adapted version of the scale, which is originally a 7-point Likert type, is a 5-point Likert type with a scoring range of 1-5 (1-Strongly disagree, 5-Strongly agree). The scale, which contains a total of 31 items, has 5 sub-dimensions: "Menstruation as a debilitating event" (7 items), "Menstruation as a disturbing event" (5 items), "Menstruation as a natural event" (5 items), "Noticing/sensing changes before and during menstruation" (8 items), "Denial of the effects of menstruation" (6 items). A high average score on the sub-dimensions or the entire scale indicates a "positive" attitude towards menstruation.
Measured: 15 minute
WaLIDD (Working ability, Location, Intensity, Days of pain, Dysmenorrhea) Scale:
It was first developed by Teherán et al. (2013) and is designed to assess the severity, duration, location, and impact on daily life of dysmenorrhea (menstrual pain) in women.
The Turkish adaptation of the scale was carried out by H. Arıkan and E. Erol and published in 2025.
Measured: 5 minute
Visual Analog Scale (VAS):
The Visual Analog Scale (VAS) was used to subjectively determine the pain of the individuals participating in the study.
Participants will be asked to indicate the intensity of their pain on a 0-10 cm scale.
1-3 cm will be considered mild, 4-7 cm moderate, and 8-10 cm severe tension.
Measured: 1 minute
Turkish Health Literacy Scale (TSOY-32):
It is a scale developed to measure individuals' ability to find, understand, evaluate, and use health information. It was adapted to the Turkish society by Abacıgil, Harlak, and Okyay (2016), based on the European Health Literacy Scale (HLS-EU-Q47). The scale, consisting of a total of 32 items, evaluates in three main areas: health services, disease prevention, and health promotion. In the validity and reliability analyses, Cronbach's α value was found to be 0.89.
Measured: 5 minute
Step Count:
The WHO defines mobile health as the support of medical and public health applications by mobile devices such as mobile phones, patient monitoring devices, and other wireless devices.
Mobile phones are the most commonly used devices in the implementation of mobile health (WHO, 2011). Many studies have reported that pedometers installed on smartphones provide accurate step counting at different walking speeds and with different carrying methods (Funk et al., 2018; Thomson et al., 2019). A-B Participants' physical activity levels were monitored for 7 days through the Google Fit application installed on smartphones. The application automatically records the daily step count, distance covered, and estimated energy expenditure using the device's accelerometer sensor. Participants were asked to keep their phones on them throughout the day and to keep the application open in the background. The average daily step count obtained at the end of 7 days was evaluated as an indicator o
Measured: 1 minute
Pittsburgh Sleep Quality Index (PSQI):
Developed by Buysse and colleagues in 1989, the PSQI is a self-report questionnaire that assesses sleep quality and disturbances over the past month.
A validity and reliability study conducted in Turkey by Ağargün and colleagues proved that the PSQI is consistent and valid in Turkish society. This scale, consisting of 24 questions, comprises 19 questions based on the individual's self-assessment and 5 questions answered by a spouse or roommate. Each question is scored between 0 and 3 to calculate the total score. A score of five or higher is generally considered poor sleep quality.
Measured: 5 minute
Short Form-12 (SF-12):
Participants' health-related quality of life was assessed using the Short Form-12 (SF-12) scale.
SF-12 is a short questionnaire consisting of two sub-dimensions, physical and mental health, measuring participants' general health status and quality of life. The physical component score (Physical Component Summary, PCS) and the mental component score (Mental Component Summary, MCS) were calculated separately, with higher scores indicating better quality of life. The Turkish validity and reliability of the scale were established by Demiral et al. (2006).
Measured: 5 minute
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Feb 2026
- Study start1 Nov 2025
- Primary completion10 Jan 2026
- Study completion10 Jan 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Menstrual ManagementStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- Generation X group Generation Y group Generation Z group
- Masking
- None (open label)
- Enrolment
- 1,200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Batman University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, merve yiğit kocamer, Batman University
- Investigators
- merve yiğit kocamer, lecturer, Principal investigator, Batman University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07382947
- Sponsor's protocol ID
- BAU-FTR-MYK-03
- Status last verified
- Jan 2026
- First submitted
- 26 Jan 2026
- Last updated
- 3 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- EXAMINING MENSTRUAL MANAGEMENT AMONG WOMEN OF DIFFERENT GENERATIONS
- ClinicalTrials.gov ID
- NCT07382947
- Acronym / sponsor ID
- BAU-FTR-MYK-03
- Keywords
- menstrual management, generational differences, womens health, menstrual health
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,200 participants (actual)
- Lead sponsor
- Batman UniversityUniversity, hospital or other
- Study start
- 1 Nov 2025 (actual)
- Primary completion
- 10 Jan 2026 (actual)
- Study completion
- 10 Jan 2026 (actual)
- First posted
- 3 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The most common symptom that occurs during the menstrual cycle is cramping pain in the lower abdomen. This pain during the menstrual cycle is called dysmenorrhea. It is one of the most common causes of pelvic pain in women. Dysmenorrhea is categorized into two types: primary and secondary. Primary dysmenorrhea manifests as painful cramps during the menstrual period without a pelvic pathology. The pain can radiate to the lower back, pelvis, and upper thigh. Although the etiology of primary dysmenorrhea is not fully known, four main causes have been identified. The etiology of primary dysmenorrhea is endocrine causes, increased prostaglandin levels, increased uterine activity, and psychological causes. Among these factors, increased uterine contractions are thought to be particularly effective in causing the pain. Ischemia in the uterus, which occurs with increased contractions, is among the factors that increase the pain. Primary dysmenorrhea has a prevalence ranging from 45% to 95%. Secondary dysmenorrhea, on the other hand, results from underlying pathological causes such as endometriosis, adenomyosis, uterine fibroids, or pelvic infections. Common symptoms of dysmenorrhea include lower abdominal pain along with headache, numbness, sleep disturbances, depression, vomiting, tender breasts, nausea, diarrhea, and increased urine output.
Detailed description
Research objective/rational: The menstrual cycle (MCC) is a physiological process lasting 23-35 days, consisting of two main phases: follicular (from menstruation to ovulation) and luteal (from ovulation to menstruation), characterized by regular fluctuations in estrogen and progesterone hormones. During the menstrual period, estrogen and progesterone levels are low, while in the follicular phase, estrogen increases and peaks at ovulation; at this time, the increase in FSH and LH triggers ovulation. In the luteal phase, progesterone levels rise and peak in the mid-luteal phase, while a second increase in estrogen levels is observed. When fertilization does not occur, both hormones rapidly decrease in the premenstrual period. Mood changes along with these hormonal fluctuations; negative mood increases during the premenstrual and menstrual periods, while positive mood increases during the ovulation period. These changes can negatively affect women's physical activities, work performance, social relationships, and quality of life. The literature reports that women lose more workdays due to health reasons compared to men, and one of the important reasons for this is symptoms associated with the menstrual cycle.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
- Model description
- Generation X group Generation Y group Generation Z group
| Arm | Type | Receives |
|---|---|---|
| X generation | Active comparator | Other: survey data entryData will be collected online (Google Forms) on a voluntary basis. At the beginning of the survey, participants will be presented with the purpose of the research, privacy principles, and an informed consent form. |
| Y Generation | Active comparator | Other: survey data entryData will be collected online (Google Forms) on a voluntary basis. At the beginning of the survey, participants will be presented with the purpose of the research, privacy principles, and an informed consent form. |
| Z Generation | Active comparator | Other: survey data entryData will be collected online (Google Forms) on a voluntary basis. At the beginning of the survey, participants will be presented with the purpose of the research, privacy principles, and an informed consent form. |
Who may qualify
- Ages
- 18 to 55 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Being female
- Being between 18-55 years of age
- Having a menstrual cycle
- Voluntarily agreeing to participate in the study
- Approving the informed consent form
Key exclusion criteria (4 listed)
- Having a serious chronic or neurological disease
- Using hormonal treatment or birth control method (within the last 6 months)
- Being pregnant or in menopause
- Having an incomplete or incorrectly completed questionnaire
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| survey data entrysurvey data entry | Other | X generation, Y Generation, Z Generation |
Primary outcome
Menstruation Symptom Scale (MSQ)
Time frame: 15 minute
Developed by Chesney and Tasto in 1975, the MSQ was adapted into Turkish by Güvenç et al. in 2014. The scale is a five-point Likert-type scale consisting of 22 items. Participants rate menstruation-related symptoms on a scale of 1 (never) to 5 (always). The scale is divided into three sub-dimensions: 'Negative Effects/Somatic Complaints', 'Menstrual Pain Symptoms', and 'Coping Mechanisms'. The MSQ score is calculated from the average scores of the items, and a higher score indicates an increase in the severity of symptoms.
Attitude Toward Menstrution Scale:
Time frame: 15 minute
Attitude Toward Menstruation Scale: The Turkish validity and reliability study of the scale developed by Brooks-Gunn and Ruble in 1980 was conducted by Kulakaç et al. in 2008. The adapted version of the scale, which is originally a 7-point Likert type, is a 5-point Likert type with a scoring range of 1-5 (1-Strongly disagree, 5-Strongly agree). The scale, which contains a total of 31 items, has 5 sub-dimensions: "Menstruation as a debilitating event" (7 items), "Menstruation as a disturbing event" (5 items), "Menstruation as a natural event" (5 items), "Noticing/sensing changes before and during menstruation" (8 items), "Denial of the effects of menstruation" (6 items). A high average score on the sub-dimensions or the entire scale indicates a "positive" attitude towards menstruation.
WaLIDD (Working ability, Location, Intensity, Days of pain, Dysmenorrhea) Scale:
Time frame: 5 minute
It was first developed by Teherán et al. (2013) and is designed to assess the severity, duration, location, and impact on daily life of dysmenorrhea (menstrual pain) in women. The Turkish adaptation of the scale was carried out by H. Arıkan and E. Erol and published in 2025.
Visual Analog Scale (VAS):
Time frame: 1 minute
The Visual Analog Scale (VAS) was used to subjectively determine the pain of the individuals participating in the study. Participants will be asked to indicate the intensity of their pain on a 0-10 cm scale. 1-3 cm will be considered mild, 4-7 cm moderate, and 8-10 cm severe tension.
Turkish Health Literacy Scale (TSOY-32):
Time frame: 5 minute
It is a scale developed to measure individuals' ability to find, understand, evaluate, and use health information. It was adapted to the Turkish society by Abacıgil, Harlak, and Okyay (2016), based on the European Health Literacy Scale (HLS-EU-Q47). The scale, consisting of a total of 32 items, evaluates in three main areas: health services, disease prevention, and health promotion. In the validity and reliability analyses, Cronbach's α value was found to be 0.89.
Step Count:
Time frame: 1 minute
The WHO defines mobile health as the support of medical and public health applications by mobile devices such as mobile phones, patient monitoring devices, and other wireless devices. Mobile phones are the most commonly used devices in the implementation of mobile health (WHO, 2011). Many studies have reported that pedometers installed on smartphones provide accurate step counting at different walking speeds and with different carrying methods (Funk et al., 2018; Thomson et al., 2019). A-B Participants' physical activity levels were monitored for 7 days through the Google Fit application installed on smartphones. The application automatically records the daily step count, distance covered, and estimated energy expenditure using the device's accelerometer sensor. Participants were asked to keep their phones on them throughout the day and to keep the application open in the background. The average daily step count obtained at the end of 7 days was evaluated as an indicator o
Pittsburgh Sleep Quality Index (PSQI):
Time frame: 5 minute
Developed by Buysse and colleagues in 1989, the PSQI is a self-report questionnaire that assesses sleep quality and disturbances over the past month. A validity and reliability study conducted in Turkey by Ağargün and colleagues proved that the PSQI is consistent and valid in Turkish society. This scale, consisting of 24 questions, comprises 19 questions based on the individual's self-assessment and 5 questions answered by a spouse or roommate. Each question is scored between 0 and 3 to calculate the total score. A score of five or higher is generally considered poor sleep quality.
Short Form-12 (SF-12):
Time frame: 5 minute
Participants' health-related quality of life was assessed using the Short Form-12 (SF-12) scale. SF-12 is a short questionnaire consisting of two sub-dimensions, physical and mental health, measuring participants' general health status and quality of life. The physical component score (Physical Component Summary, PCS) and the mental component score (Mental Component Summary, MCS) were calculated separately, with higher scores indicating better quality of life. The Turkish validity and reliability of the scale were established by Demiral et al. (2006).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Menstrual Management
Active, not recruiting
An MHH Intervention in Bangladesh Health Systems
Menstrual Health Intervention, Product Use Issue
Enrolling by invitation
Effect of Hygiene and Menstrual Hygiene Interventions on Learning and Psychosocial Wellbeing in Madagascar
Urinary Tract Infections, Malnutrition
Recruiting
Effectiveness and Acceptability of Insertable Devices for Obstetric Fistula Management
Obstetric Fistula, Fistula
RecruitingObservational study
Hormonal Management of Heavy Menstrual Bleeding in Adolescents
Heavy Menstrual Bleeding, Bleeding Disorder
Enrolling by invitation
Pelvic Floor and Diaphragmatic Breathing Exercises for Primary Dysmenorrhea
Primary Dysmenorrhea (PD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
merve yiğit kocamer, lecturer principal investigator
Batman University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing survey data entry in people with Menstrual Management and Generational Differences, run by Batman University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Menstruation Symptom Scale (MSQ) (time frame: 15 minute). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2026.